Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2026 Declaration of 1st Interim Dividend 2026-2027

AHCL/SE/34/2026-27 October 27, 2026 The National Stock Exchange of India BSE Limited Limited Department of Corporate Services “Exchange Plaza”, C-1, Block G 1st Floor, Bandra-Kurla Complex, Bandra (E) P.J. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 ISIN: INE098F01031 Symbol : AMRUTANJAN Scrip Code: 590006 Dear Sir/ Madam, Sub: Intimation under Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Pursuant to the above mentioned regulation of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 , we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday, 3rd November 2026 through Video Conferencing, 1. To consider and approve, inter-alia, the Unaudited Financial Results along with the Limited Review Report by the Statutory Auditors for the quarter and half year ended September 30, 2026. 2. Declaration of 1st Interim Dividend for the financial year 2026-27. It may also be noted that as already informed vide our letter dated 25th September 2026, the Trading Window for dealing in equity shares of the Company is closed effective from 1st October, 2026 and will remain closed till 5th November 2026 pursuant to SEBI (PIT) Regulations, 2015 and in terms of Code of Conduct to regulate, monitor and report trading in securities of the Company. Request to take the above on record and acknowledge. Thanking You, Yours faithfully For Amrutanjan Health Care Limited (Gagan Preet Singh) General Manager - Legal Company Secretary & Compliance Officer Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail : customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 CIN Tel :+91-44 - 2499 4465 - L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585